đ
The FDA has approved the drug Relyvrio, which was shown in studies to extend the lives of people with ALS by about 6 months.
FDA Approves AMX0035 (Relyvrio) for ALS
Posted in biotech/medical
Posted in biotech/medical
đ
The FDA has approved the drug Relyvrio, which was shown in studies to extend the lives of people with ALS by about 6 months.